BioClin Therapeutics

BioClin Therapeutics

BioClin Therapeutics

Our Mission. A biotech company devoted to identifying and developing treatmentsfor disorders with high unmet needs.
Raised
$50M
Follow us
Alexa global traffic share
Latest funding
$20,000,000
Venture capital (Series B) - 2018
INKEF Capital HealthCap Sofinnova Ventures +4
$30,000,000
Venture capital (Series B) - 2017
Life Sciences Partners HealthCap Sofinnova Ventures +3
Team Size
10+
Employees
$20,000,000 Venture capital (Series B)
FinSMEs

BioClin Therapeutics Raises $20M; Completes $50M Series B Financing

Funding Health
$30,000,000 Venture capital (Series B)
PE HUB , Xconomy

BioClin Therapeutics inks $30 mln Series B

Messaging Funding Data leaks